Healthy weight and controlled feeding in dogs
Strongest direct dog longevity signal in this seed set, with important breed, diet and study-sponsor limitations.
Open record →Interventions
What may help—and what is still only a hypothesis?
Compare measured outcomes, species, study design, safety boundaries and commercial claims without converting human doses into pet advice.
Rapamycin for dog longevity
Research to watch, not an owner-directed longevity treatment.
Open record →NMN for dogs
Research hold: do not translate human longevity content into a canine dose or lifespan claim.
Open record →NMN for cats
Research hold: no feline dose or lifespan forecast is published by PawCosts.
Open record →EPA and DHA omega-3 for canine osteoarthritis
Condition-specific mobility evidence exists; formulation, diagnosis, total diet and veterinary safety review still matter.
Open record →MCT-enriched diet for canine cognitive dysfunction
Relevant canine cognition evidence, but it does not demonstrate an ageing-prevention effect or extended life from standalone MCT oil.
Open record →Undenatured type II collagen for dog mobility
A mobility evidence topic—not a pet-longevity proof or a reason to copy a study dose.
Open record →Therapeutic renal diets for cats with chronic kidney disease
One of the stronger cat survival evidence areas, limited to veterinarian-diagnosed CKD and specific therapeutic nutrition.
Open record →Vitamin E supplementation for cats with chronic kidney disease
A valuable negative result: an antioxidant rationale did not become a demonstrated feline survival benefit in this trial.
Open record →